Evidence map›Paper›PMID 37583962›Full record

ArticleERJ open research2023

A typology of healthcare pathways after hospital discharge for adults with COVID-19: the evolution of UK services during pandemic conditions.

Linzy Houchen-Wolloff, Charlotte Overton, Andrew Ibbetson, Archie Walters, Claire Hastie, Rhyan Gill, Natalie Armstrong, Sally Singh, Paul Little, Kirby Evans and 6 more

Open access · goldAbstract read
In one paragraph

Article in ERJ open research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 1 country.

Linzy Houchen-WolloffLeicester NIHR Biomedical Research Centre - Respiratory, University Hospitals of Leicester NHS Trust, Leicester, UK.
Charlotte OvertonSAPPHIRE, Department of Population Health Sciences, College of Life Sciences, University of Leicester, Leicester, UK.
Andrew IbbetsonDepartment of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK.
Archie WaltersDepartment of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK.ORCID https://orcid.org/0000-0001-6614-8452
Claire HastieLong COVID Support, Birmingham, UK.
Rhyan GillLeicester NIHR Biomedical Research Centre- Respiratory Patient and Public Involvement Group, University Hospitals of Leicester NHS Trust, Leicester, UK.
Natalie ArmstrongSAPPHIRE, Department of Population Health Sciences, College of Life Sciences, University of Leicester, Leicester, UK.
Sally SinghLeicester NIHR Biomedical Research Centre - Respiratory, University Hospitals of Leicester NHS Trust, Leicester, UK.ORCID https://orcid.org/0000-0002-9834-0366
Paul LittleDepartment of Medicine, University of Southampton, Southampton, UK.
Kirby EvansOxford Health NHS Foundation Trust, Oxford, UK.
John PimmOxford Health NHS Foundation Trust, Oxford, UK.
Michael MarksDepartment of Clinical Research, London School of Hygiene and Tropical Medicine, London, UK.ORCID https://orcid.org/0000-0002-7585-4743
Krisnah PoinasamyAsthma and Lung UK, London, UK.
Sam WalkerAsthma and Lung UK, London, UK.
Andrew BriggsDepartment of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK.
Rachael A EvansLeicester NIHR Biomedical Research Centre - Respiratory, University Hospitals of Leicester NHS Trust, Leicester, UK.ORCID https://orcid.org/0000-0002-1667-868X
University of Leicester · GBLondon School of Hygiene & Tropical Medicine · GBAsthma UK · GBOxford Health NHS Foundation Trust · GBUniversity College Hospital · GBUniversity Hospitals of Leicester NHS Trust · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Over half of post-COVID-hospitalisation adults have persistent symptoms 2 years after discharge, providing a challenge for individuals and healthcare systems. We therefore aimed to describe a typology of UK healthcare pathways post-hospital discharge as a first step towards understanding clinical effectiveness and cost-effectiveness of different healthcare pathways. Methods: In 2021, we surveyed hospital sites taking part in the UK Post-hospital COVID-19 (PHOSP-COVID) study. The online survey explored the availability of proactive follow-up, patient selection, involvement of multidisciplinary teams, investigations, assessment and access to mental health and rehabilitation interventions. The typology was defined by a three-stage process: 1) using the survey results to develop a bespoke algorithm to inform a draft classification, 2) a stakeholder event for refinement and 3) finalisation between the Project Advisory Group and research team. The bespoke algorithm was used to map each site onto the classification with further mapping by level of mental health and rehabilitation provision. Results: 70% of hospital sites (45 out of 64) responded to the survey. 82% (37 out of 45) reported delivering a follow-up service after hospital discharge during the first few months of the pandemic. Only 13 out of 37 services (35%) were delivered by permanent staff. The final typology of five categories included no proactive follow-up, and a matrix of four groups based on patient selection (prespecified subgroup/all patients) and complexity of assessment (low/high). The complexity of assessment, rehabilitation and mental health interventions was variable within sites. Discussion: We describe the first typology of post-hospitalisation COVID-19 healthcare pathways to enable modelling of clinical effectiveness and cost-effectiveness to inform future policy. Our results highlight the heterogeneity and vulnerability of healthcare services after COVID-19 hospitalisation.

Identifiers

PMID37583962
PMCPMC10423987
OpenAlexW4376134482

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.